FMP
Agile Therapeutics, Inc.
AGRX
NASDAQ
Inactive Equity
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
1.51 USD
0.05 (3.31%)
AGRX Financial Statements
Year
2023
2022
2021
2020
Current Assets
9.53M
11.36M
23.93M
56.78M
Cash & Short Term Investments
2.56M
5.25M
19.14M
54.47M
Cash And Cash Equivalents
2.56M
5.25M
19.14M
14.46M
Short Term Investments
0
0
0
40.01M
Net Receivables
3.39M
3.38M
1.53M
865k
Inventory
2.74M
1.33M
966k
1
Other Current Assets
402k
1.4M
2.28M
1.45M
Non-Current Assets
725k
2.88M
15.41M
16.28M
Property, Plant & Equipment
487k
872k
13.4M
14.38M
Goodwill And Intangible Assets
0
0
0
0
Goodwill
0
0
0
0
Intangible Assets
0
0
0
0
Long Term Investments
0
0
0
0
Tax Assets
0
0
0
0
Other Non-Current Assets
238k
2.01M
2.01M
1.9M
Other Assets
0
0
0
0
Total Assets
10.26M
14.24M
39.33M
73.06M
-
-
-
-
Current Liabilities
20.78M
13.39M
29.28M
7.35M
Accounts Payable
9.57M
7.73M
8.71M
3.87M
Short Term Debt
1.71M
1.75M
17.01M
138k
Tax Payables
0
0
0
0
Deferred Revenue
0
0
0
0
Other Current Liabilities
832k
514k
1.91M
1.56M
Total Current Liabilities
20.78M
13.39M
29.28M
7.35M
Total Non-Current Liabilities
5.8M
6.4M
784k
16.38M
Long-Term Debt
0
0
0
16.38M
Deferred Revenue
0
0
0
0
Deferred Taxes Liabilities
0
0
0
0
Other Non Current liabilities
5.7M
5.93M
5.36M
0
Total Liabilities
26.57M
19.79M
30.06M
23.73M
Other Liabilities
0
0
0
0
Stockholders Equity
-16.32M
-5.54M
9.27M
49.33M
Common Stock
4k
4k
12k
9k
Retained Earnings
-423.17M
-408.7M
-387.12M
-312.22M
Accumulated Other Comprehensive Income/Loss
0
0
0
3k
Other Shareholders Equity
0
-4k
0
0
Total Liabilities and Stockholders Equity
10.26M
14.24M
39.33M
73.06M
All figures are in USD.
